He says his doctor told him only 5 percent of cancer patients who could be eligible for trials are aware of them. " Holding disease at bay Cossman is one of 16 patients with progressive forms of cancer currently taking part in a study of a developmental drug by the Cambridge, Massachusetts-based Cerulean Pharma. Cossman is one of the tens of thousands of people worldwide enrolled in drug trials. Cossman learned of drug trials through his oncologist --"otherwise, I'd know nothing about them." To remain in a trial, tumor growth has to be limited to 20 percent.